Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
14,462,317
-
Share change
-
+641,265
-
Total reported value
-
$107,736,409
-
Price per share
-
$7.45
-
Number of holders
-
48
-
Value change
-
+$5,043,456
-
Number of buys
-
23
-
Number of sells
-
20
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2020
As of 31 Dec 2020,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,462,317 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Sonic Fund II, L.P., Avoro Capital Advisors LLC, EVENTIDE ASSET MANAGEMENT, LLC, 683 Capital Management, LLC, BlackRock Inc., Solas Capital Management, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, STATE STREET CORP, and Russell Investments Group, Ltd..
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.